Caffeine Intake and Periodontal Treatment Outcomes | NCT07747545

NCT07747545

Overview

NCT ID: NCT07747545
Lead Sponsor: Haoran FengOTHER
Official Title: Effects of Dietary Caffeine Intake on Periodontal Treatment Outcomes: A Randomized Controlled Trial
Brief Summary: This study will explore whether caffeine intake can affect recovery after periodontal (gum) treatment.

Periodontitis is a common gum disease caused by bacteria. Even after treatment, some people may still have ongoing inflammation or changes in oral bacteria. Researchers want to know if daily caffeine intake, such as from coffee, may help improve this condition.

In this study, about 90 adults with periodontitis will receive standard periodontal treatment. Participants will be randomly assigned to one of three groups: no caffeine intake, low caffeine intake, or moderate caffeine intake. They will follow these instructions for about 6 months.

Researchers will collect saliva samples and check gum health at several time points after treatment. Saliva will be used to measure inflammation markers and to study changes in oral bacteria. Researchers will also record clinical gum conditions, such as gum pocket depth and bleeding.

The goal of this study is to understand whether caffeine intake can help reduce inflammation, improve oral bacteria balance, and support recovery after periodontal treatment. The results may help provide simple dietary advice to improve long-term gum health.

Status and Timeline

Status: Not yet recruiting
Last Update Posted: Aug 5, 2026Actual
Start Date: Aug 1, 2026Estimated
Primary Completion Date: Dec 31, 2027Estimated

Participation Criteria

Ages Eligible for Study: Adult (18-64)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Adults aged 18 to 55 years.

Diagnosed with periodontitis according to the 2018 Classification of Periodontal and Peri-Implant Diseases and Conditions.

First visit for periodontal treatment and eligible for standard non-surgical periodontal therapy.

Willing and able to comply with the dietary intervention and scheduled follow-up visits.

Able to understand the study procedures and provide written informed consent.

Able to communicate effectively and complete study questionnaires and follow-up assessments.

Exclusion Criteria:

Pregnant or breastfeeding women, or women planning pregnancy during the study period.

History of periodontal treatment within the previous 6 months.

Current smokers or tobacco users.

Use of antibiotics, anti-inflammatory drugs, immunosuppressive agents, or medications known to affect periodontal status within the previous 3 months.

Presence of systemic diseases that may influence periodontal conditions, including diabetes mellitus, hypertension, or hyperlipidemia.

Severe systemic diseases, psychiatric disorders, or other conditions that may interfere with study participation or protocol compliance.

Allergy or intolerance to caffeine or inability to comply with the dietary caffeine intervention.

Individuals with limited hand function or other conditions preventing adequate oral hygiene practices.

Study Plan

Study Type: Interventional
Phase: Not Applicable
Enrollment: 90Estimated
Primary Purpose: Treatment
Allocation: Randomized
Interventional Model: Parallel Assignment
Masking

Contacts and Locations

Central Contacts: Haoran Feng, BSContact
fenghaoran0611@gmail.com

Similar Studies

Participant Group/Arms

No Caffeine Intake GroupExperimental

Participants will receive standard non-surgical periodontal treatment and will be instructed to avoid dietary caffeine intake throughout the 6-month study period.

Dietary Supplement: No Caffeine Intake

Low Caffeine Intake GroupExperimental

Participants will receive standard non-surgical periodontal treatment and will consume approximately 50 mg of dietary caffeine per day throughout the 6-month study period.

Dietary Supplement: Low Caffeine Intake

Moderate Caffeine Intake GroupExperimental

Participants will receive standard non-surgical periodontal treatment and will consume approximately 100 mg of dietary caffeine per day throughout the 6-month study period.

Dietary Supplement: Moderate Caffeine Intake

NCT03073161Completed

Flavonoid Intake and Periodontal Healing

NCT02291835Completed

Dietary Intakes and Periodontal Outcomes After Sanative Therapy

NCT05681325Unknown status

Evaluation of Antioxidant and Anti-inflammatory Effect of Matcha Tea Intake on Periodontal Health

NCT00327561Completed

Effect of Intensive Periodontal Therapy on Vascular Function

NCT06753682Recruiting

Healthy Plant-based Diet and Periodontal Treatment

NCT03073174Completed

Dietary Intakes and Periodontal Health: A Follow-Up Study

NCT05120206Completed

The Impact of Cigarette Smoking on Periodontal Therapy

NCT07287540Recruiting

Anti-inflammatory Nutrition on the Outcomes of Non-surgical Periodontal Therapy